Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic

dc.contributor.author	Schwartz, EC
dc.contributor.author	Huss, R
dc.contributor.author	Hopkins, A
dc.contributor.author	Dadjim, B
dc.contributor.author	Madjitoloum, P
dc.contributor.author	Hénault, C
dc.contributor.author	Klauss, V
dc.date.accessioned	2013-06-18T11:43:59Z
dc.date.available	2013-06-18T11:43:59Z
dc.date.issued	1997
dc.identifier.citation	Br J Ophthalmol. 1997 Jun;81(6):443-7	en
dc.identifier.uri	http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/9274406
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/35558
dc.description.abstract	AIMS: A population based survey of blindness and visual impairment was conducted in the district of Bossangoa, Central African Republic. METHODS: A total of 48 communities were randomly selected, and 6086 people examined. RESULTS: The prevalence of blindness (visual acuity in the better eye less than 3/60) was 2.2%, and visual impairment 3.0% (6/24 to 3/60 in the better eye). The major causes of blindness were onchocerciasis (73.1%), cataract (16.4%), trachoma (4.5%), and glaucoma (2.2%). CONCLUSION: Around 95.5% of all blindness could potentially have been prevented or treated. Ivermectin mass distribution is hoped to prevent 50% of all forms of visual loss in the future	en
dc.language.iso	en	en
dc.title	Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic	en
dc.type	Article	en
local.publisher	University Eye Clinic LMU, Munich, Germany	en